COMPANY PROFILE

Escalier Biosciences

Explore full profile

Advancing the treatment of autoimmune disease

Nijmegen, NetherlandsFounded 2016Biotech & Life Sciences

Valuation $50–100M Last recorded · 2018

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Escalier Biosciences

Escalier Bio is a biotechnology company focused on developing microRNA-based therapeutics to address complex, multifactorial diseases. The company operates in the biopharmaceutical market, targeting clients such as healthcare providers, research institutions, and pharmaceutical companies. Escalier Bio's business model revolves around the research, development, and commercialization of novel drug therapies that leverage the regulatory power of microRNAs. These small, non-coding RNA molecules can influence the expression of hundreds of genes, making them potent tools for treating diseases with complex genetic underpinnings. Revenue is generated through partnerships, licensing agreements, and direct sales of their therapeutic products.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Nijmegen, Netherlands
Employees: 1
Open positions: None listed
Dealroom signal: 25.3/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Autoimmune, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Mar 2018	$17M	$66M	BioGeneration Ventures · New Science Ventures · Forbion Capital Partners	—
SERIES A✓Equity / VC	Mar 2017	$0	—	BioGeneration Ventures · New Science Ventures	—

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Escalier Biosciences website traffic

Latest recorded traffic for Escalier Biosciences is 230 monthly website visits, up 0% over the last three months. Escalier Biosciences's team grew 0% over the past year.

Latest monthly visits230 3-month web change0% 1-year team growth0%

Monthly website visitsApr 2017–May 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
TTTopas TherapeuticsHarnessing the liver’s natural immunology capabilities to address areas of major unmet medical need	Hamburg, Germany	Operational	22	$64M	$121M
EPEnthera PharmaceuticalsDeveloping first-in-class biologics for several underserved autoimmune conditions	Milan, Italy	Operational
CBConnect BiopharmaceuticalsConnect Biopharmaceuticals, Ltd. is a clinical-stage company that discovers	Suzhou Shi, China	Operational
LBLandos BiopharmaA clinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for patients with autoimmune disease	Ashtabula, United States	Acquired
LHLegacy HealthcareBiopharma developing innovative botanical drugs in supportive oncology care and dermatology	Epalinges, Switzerland	Operational
KMKAHR MedicalDeveloping an innovative and novel drug platform of immunotherapeutic bi-functional fusion proteins that harness the human immune system to target multiple cancer indications	Jerusalem, Israel	Operational
CPCannabics PharmaceuticalsCannabics Pharmaceuticals Inc. (CNBX) is a U.S public company that is developing a platform that leverages novel drug-screening tools and AI	Caesarea, Israel	Operational
CBCan-Fite BioPharmaA biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities	Petah Tikva, Israel	Operational